Similar Jobs
See allThe Role:
- Lead late-stage drug substance process development and CMC strategy.
- Manage tech transfer and PPQ activities across CDMOs.
What We Look For:
- 8+ years in pharmaceutical drug substance development with R&D and GMP expertise.
- Strong CDMO oversight, regulatory CMC, and QbD/DoE experience.
Why Pulmovant:
- Work on a Phase 3 asset with strong clinical data.
- Join a collaborative Roivant-backed biotech culture.
Pulmovant
Pulmovant is a Roivant-backed clinical-stage biotech developing inhaled therapies for pulmonary diseases. Its lead candidate, mosliciguat, is in Phase 3 for PH-ILD, and the company operates with a collaborative, fast-paced Roivant culture.